LOUISVILLE, Ky. — Patients with primary immunodeficiency disease experienced fewer infections during the COVID-19 lockdown, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
These observed reductions may be due to isolation and/or fewer interactions with physicians, Marie Sanchirico, PhD, senior medical director of rare immunology at Takeda Pharmaceuticals USA, said during her presentation.
“Primary immunodeficiencies [PID] can arise from over 450 inborn errors of immunity, and patients with PID often suffer from